Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
tick toc tick toc just waiting I guess your turn Mr. CEO
something is brewing hopeful good
So what are trying to show sir
I hear you Bob any info would be great
FDA Painkiller Restrictions could boost NYLOXIN - Coverage Initiated on NPHC
h
WASHINGTON, (Reuters) - The U.S. Food and Drug Administration recommended tighter restrictions on products that contain hydrocodone, an opioid painkiller present in commonly prescribed, potentially addictive drugs such as Vicodin.
Nyloxin is a non addictive option to opiate based painkillers. It is posed to take advantage of the new restrictions. Marketing Nyloxin as a non addictive painkiller at the same time the FDA restricts opiate based painkiilers could be very beneficial to NPHC shareholders We may see increased interest in the security NPHC.
FDA Painkiller Restrictions could boost NYLOXIN - Coverage Initiated on NPHC
http://www.huffingtonpost.com/2013/10/24/fda-hydrocodone-painkillers-access_n_4159316.html
WASHINGTON, - The U.S. Food and Drug Administration recommended tighter restrictions on products that contain hydrocodone, an opioid painkiller present in commonly prescribed, potentially addictive drugs such as Vicodin.
Nyloxin is a non addictive option to opiate based painkillers. It is posed to take advantage of the new restrictions. Marketing Nyloxin as a non addictive painkiller at the same time the FDA restricts opiate based painkiilers could be very beneficial to NPHC shareholders We may see increased interest in the security NPHC.
LITTLE INFO PLEASE NO NEWS IS NOT GOOD NEWS
THE CALM BEFORE THE STORM
Patience young grasshoppers patience[color=red]
on the brink going north
Boca Raton, FL >>> cobrynol >>> Ocean Pharmaceuticals
Coral Springs, FL >> Cobroxin >>> Nutra Pharma Corporation
less than 10 min away from each other (very interesting)
http://www.cobrynol.com/products <<< FYI interesting
AMEN
keys to a winner
1)good product (check)
2)marketing (check)
3)profit (maybe ?????)
THANK YOU
game on
It's crap or get off the pot time. yeah!
Throwing everything in even the kitchen sink.Good Luck to all,sincerely!!!
Marketing is the only thing left that this puzzle needs. I will go 20% yes. Maybe that is enough for some. Good Luck to all.
wow don't sell the cow yet
it can only go down for so long and then the night mare will be over
reality check 4/23/2013 share price .0054
wow the beginning of the end
The product is homeopathic. That eliminates alot of potential customers right there. It has never been tested in a double blind clinical test in its present concentration. It is also priced too high versus the competition. Also it lacks advertising and the money to properly introduce the product to the market.Read it fast it will get deleted because I am not one of the chosen ones.
HELLO, IS THIS STOCK COMING BACK TO LIFE MAYBE
for those that don't twitter http://www.jgcaf.org/
Jeffrey Gottfurcht
I reached base camp at 17,500ft! I will rest here for a few days, then climb Lobuche Peak, 20,075ft. 15 minutes ago
Jeffrey Gottfurcht
I leave in 20 days to attempt to be the first person with RA to climb Everest. It will take about 10 days to hike to base camp and than roughly six weeks to get to the top and back down!!! You will be able to follow the whole climb here!! Lets make the impossible -POSSIBLE!!!!!!!!
MARCH 26TH 2011 possible start date
Teva's proprietary research and development pipeline is currently focused primarily on three niche specialty areas: neurological disorders, autoimmune diseases and oncology. Currently there are several innovative products in advanced development stages for the treatment of Multiple sclerosis, Crohn's disease , ALS and more.
Just RUMORS yet!!!!!!!
Why pink????
http://shortsqueeze.com/?symbol=nphc&submit=Short+Quote%99 he shorts are running
Maybe something for NPHC to tackle
http://news.yahoo.com/s/afp/20110130/hl_afp/healthdiseasecancertobacconicotinegenetics
because
http://www.receptopharm.com/drug_development/research_platform.php
When are going to get the Nyloxin web site going as ordering goes
Liver damage -Big pharma maybe looking for natural painkiller and that alone would be million or billions
Marketing the key.If you think really,NPHC gotten this far with little no marketing @ all is good.Hopefully now they got all their ducks in a row.Game on!!!!
758,000